Chemical Compound

1(2H)-Phthalazinone, 4-[[3-[[4-(cyclopropylcarbonyl)-1-piperazinyl]carbonyl]-4-fluorophenyl]methyl]-; Piperazine, 1-(cyclopropylcarbonyl)-4-[5-[(3,4-dihydro-4-oxo-1-phthalazinyl)methyl]-2-fluorobenzoyl]- (9CI); 4-[[3-[[4-(Cyclopropylcarbonyl)-1-piperazinyl]carbonyl]-4-fluorophenyl]methyl]-1(2H)-phthalazinone; 4-(3-(4-(Cyclopropanecarbonyl)piperazine-1-carbonyl)-4-fluorobenzyl)phthalazin-1(2H)-one; AZD 2281; KU 0059436; KU 59436; Lynparza; Olaparib

CAS Registry Number 763113-22-0
返回搜索 申请报价
1(2H)-Phthalazinone, 4-[[3-[[4-(cyclopropylcarbonyl)-1-piperazinyl]carbonyl]-4-fluorophenyl]methyl]-; Piperazine, 1-(cyclopropylcarbonyl)-4-[5-[(3,4-dihydro-4-oxo-1-phthalazinyl)methyl]-2-fluorobenzoyl]- (9CI); 4-[[3-[[4-(Cyclopropylcarbonyl)-1-piperazinyl]carbonyl]-4-fluorophenyl]methyl]-1(2H)-phthalazinone; 4-(3-(4-(Cyclopropanecarbonyl)piperazine-1-carbonyl)-4-fluorobenzyl)phthalazin-1(2H)-one; AZD 2281; KU 0059436; KU 59436; Lynparza; Olaparib 结构式
Primary record

1(2H)-Phthalazinone, 4-[[3-[[4-(cyclopropylcarbonyl)-1-piperazinyl]carbonyl]-4-fluorophenyl]methyl]-; Piperazine, 1-(cyclopropylcarbonyl)-4-[5-[(3,4-dihydro-4-oxo-1-phthalazinyl)methyl]-2-fluorobenzoyl]- (9CI); 4-[[3-[[4-(Cyclopropylcarbonyl)-1-piperazinyl]carbonyl]-4-fluorophenyl]methyl]-1(2H)-phthalazinone; 4-(3-(4-(Cyclopropanecarbonyl)piperazine-1-carbonyl)-4-fluorobenzyl)phthalazin-1(2H)-one; AZD 2281; KU 0059436; KU 59436; Lynparza; Olaparib

库存
2,621 克
纯度
99.1 %
CAS
763113-22-0

化合物标识与属性

CAS
763113-22-0
PubChem CID
23725625
SMILES
C1CC1C(=O)N2CCN(CC2)C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F
Canonical SMILES
O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1

名称与同义词

  • Olaparib
  • Lynparza
  • 763113-22-0
  • AZD2281
  • Olaparibum
  • AZD-2281
  • OLAPARIB cpd
  • Olaparib [INN]
  • KU-0059436
  • WOH1JD9AR8
  • AZD 2281
  • Lynparza (TN)
  • Olaparib [USAN:INN]
  • Olaparib (AZD-2281)
  • UNII-WOH1JD9AR8
  • Olaparib (Standard)
  • Olaparib (AZD2281)
  • AZD2281(olaparib)
  • OLAPARIB [USAN]
  • RefChem:57006
  • OLAPARIB [JAN]
  • C24H23FN4O3
  • OLAPARIB [MI]
  • OLAPARIB [VANDF]
  • Acylpiperazine analogue, 47
  • Olaparib - AZD2281
  • OLAPARIB [MART.]
  • KU-59436
  • MFCD13185161
  • cc-16
  • D0J9HW
  • OLAPARIB [WHO-DD]
  • Olaparib, KU-0059436
  • Olaparib,ku-0059436
  • Olaparib (AZD2281, Ku-0059436)
  • Olaparib (DISCONTINUED)
  • PARP inhibitor AZD2281
  • AZD221
  • AZ2281
  • Olaparib (JAN/USAN/INN)
  • AZD-2281 (Olaparib)?
  • CHEBI:83766
  • MLS006010185
  • Olaparib - Bio-X trade mark
  • 1-(Cyclopropylcarbonyl)-4-[5-[(3,4-dihydro-4-oxo-1-phthalazinyl)methyl]-2-fluorobenzoyl]piperazine
  • NSC-747856
  • SCHEMBL426568
  • DTXSID60917988
  • OLAPARIB [ORANGE BOOK]
  • CHEMBL521686
  • GTPL7519
  • orb1304620
  • SCHEMBL29352148
  • SCHEMBL29392087
  • AZ-2281
  • BDBM27566
  • CTK8B3857
  • KS-00000HXY
  • AOB1085
  • EX-A002
  • L01XX46
  • FDLYAMZZIXQODN-UHFFFAOYSA-N
  • 4-(3-(4-(Cyclopropanecarbonyl)piperazine-1-carbonyl)-4-fluorobenzyl)phthalazin-1(2H)-one
  • BCPP000360
  • DTXCID001346944
  • GLXC-02796
  • HMS3295I09
  • HMS3426C03
  • HMS3654G13
  • HMS3746K07
  • HMS3870H03
  • HMS5079O07
  • HMS6019J08
  • AMY10295
  • BCP01872
  • KEYLYNK-010 COMPONENT OLAPARIB
  • KU59436
  • ABP000423
  • AN-493
  • ANW-43329
  • EBC-11384
  • HY-10162R
  • NSC747856
  • NSC753686
  • s1060
  • ZINC40430143
  • KU 59436
  • AKOS005145764
  • AC-7939
  • ACN-032229
  • AN-5279
  • BCP9000363
  • CCG-264799
  • CS-0075
  • DB09074
  • EX-7210
  • FO33122
  • NSC 747856
  • NSC-753686
  • QC-2660
  • RL04905
  • SB14617
  • SS-4573
  • AZD2281,Olaparib, KU-0059436
  • NCGC00238451-01
  • NCGC00238451-02
  • NCGC00238451-08
  • NCGC00238451-09
  • NCGC00238451-11
  • 4CA-0938
  • AK-40514
  • BC245405
  • BO164169
  • BP-43641
  • BR-40514
  • CID:23725625
  • EN002690
  • HY-10162
  • KU-59346
  • Olaparib (AZD2281, KU0059436)
  • SC-65060
  • SMR004701291
  • SY040527
  • Olaparib (AZD2281; Ku-0059436)
  • OLAPARIB COMPONENT OF KEYLYNK-010
  • SID:134222742
  • AB0009952
  • AB1009702
  • AJ-101717
  • KU0059436
  • Olaparib(AZD2281,KuDOSKU-0059436)
  • Olaparib, 99%, PARP inhibitor - 1G 1g
  • A4154
  • A9666
  • BB 0260909
  • FT-0651458
  • KU-0059346
  • NS00072449
  • SW218142-2
  • EC-000.2324
  • J2.765.098H
  • 4-[[3-[4-(Cyclopropanecarbonyl)piperazine-1-carbonyl]-4-fluorophenyl]methyl]-2H-phthalazin-1-one
  • A10111
  • D09730
  • S-3781
  • S-7836
  • Z-3275
  • |A-Chloro-p-tolunitrile; 4-Cyanobenzyl chloride
  • EN300-7542225
  • AZD2281(olaparib)/AZD-2281/KU0059436
  • C531550
  • F043403
  • 937799-91-2
  • I06-2362
  • Q7083106
  • 4-(3-{[4-(Cyclopropylcarbonyl)piperazin-1-Yl]carbonyl}-4-Fluorobenzyl)phthalazin-1(2h)-One
  • 4-[3-(4-Cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one
  • BRD-K02113016-001-08-9
  • BRD-K02113016-001-09-7
  • BRD-K02113016-001-15-4
  • BRD-K02113016-001-19-6
  • 1-(cyclopropylcarbonyl)-4-[5-[(3,4-dihydro-4-oxo-1
  • Z2227698469
  • AZD 2281|||KU 0059436|||KU 59436
  • B0084-076683
  • 4-[(3-{[4-Cyclopropylcarbonyl)piperazin-4-yl]carbonyl}-4-fluorophenyl)methyl]phtalazin-1(2H)-one
  • 4-[[3-[[4-(Cyclopropylcarbonyl)-1-piperazinyl]carbonyl]-4-fluorophenyl]methyl]-1(2H)-phthalazinone
  • 4-{[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorophenyl]methyl}-1,2-dihydrophthalazin-1-one
  • Olaparib, KU-0059436, AZD2281,KU0059436, AZD2281
  • 1(2H)-Phthalazinone, 4-[[3-[[4-(cyclopropylcarbonyl)-1-piperazinyl]carbonyl]-4-fluorophenyl]methyl]-
  • 4-[(3-{[4-(Cyclopropylcarbonyl)piperazin-1-yl]carbonyl}-4-fluorophenyl)methyl]phthalazin-1(2H)-one
  • 4-[[3-[4-(cyclopropanecarbonyl)piperazine-1-carbonyl]-4-fluoro-phenyl]methyl]-2H-phthalazin-1-one
  • 4-(3-((4-(cyclopropylcarbonyl)piperazin-1-yl)carbonyl)-4-fluorobenzyl)phthalazin-1(2H)-one
  • 4-(3-{[4-(Cyclopropylcarbonyl)-1-piperazinyl]carbonyl}-4-fluorobenzyl)-1(2H)-phthalazinone
  • 4-[3-[4-(Cyclopropanecarbonyl)piperazine-1-carbonyl]-4-fluorobenzyl]phthalazin-1(2H)-one
  • cyclopropanecarbonyl)piperazine-4-carbonyl)-4-fluorobenzyl)phthalazin-1(2H)-one
  • (2H)-Phthalazinone, 4-((3-((4-(cyclopropylcarbonyl)-1-piperazinyl)carbonyl)-4-fluorophenyl)methyl)-
  • 09L
  • 1(2H)-Phthalazinone, 4-[[3-[[4-(cyclopropylcarbonyl)-1-piperazinyl]carbonyl]-4-fluorophenyl]methyl]-; Piperazine, 1-(cyclopropylcarbonyl)-4-[5-[(3,4-dihydro-4-oxo-1-phthalazinyl)methyl]-2-fluorobenzoyl]- (9CI); 4-[[3-[[4-(Cyclopropylcarbonyl)-1-piperazinyl]carbonyl]-4-fluorophenyl]methyl]-1(2H)-phthalazinone; 4-(3-(4-(Cyclopropanecarbonyl)piperazine-1-carbonyl)-4-fluorobenzyl)phthalazin-1(2H)-one; AZD 2281; KU 0059436; KU 59436; Lynparza; Olaparib
  • 1021843-02-6
  • 4-((3-((4-(CYCLOPROPYLCARBONYL)PIPERAZIN-1-YL)CARBONYL)-4-FLUOROPHENYL)METHYL)PHTHALAZIN-1(2H)-ONE
  • 4-((3-(4-(cyclopropanecarbonyl)piperazine-1-carbonyl)-4-fluorophenyl)methyl)-2H-phthalazin-1-one
  • 4-((3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorophenyl)methyl)-1,2-dihydrophthalazin-1-one
  • 4-((3-{(4-(cyclopropylcarbonyl)piperazin-1-yl)carbonyl}-4-fluorophenyl)methyl)phthalazin-1(2H)-one
  • 4-({3-[(4-cyclopropanecarbonylpiperazin-1-yl)carbonyl]-4-fluorophenyl}methyl)-1,2-dihydrophthalazin-1-one
  • 4-({3-[4-(Cyclopropanecarbonyl)piperazine-1-carbonyl]-4-fluorophenyl}methyl)phthalazin-1(2H)-one
  • 4-[[3-[[4-(Cyclopropylcarbonyl)-1-piperazinyl]carbonyl]-4-fluorophenyl]methyl]-1(2H)-phthalazinone; AZD 2281; KU 0059436; KU 59436; 1-(Cyclopropylcarbonyl)-4-[5-[(3,4-dihydro-4-oxo-1-phthalazinyl)methyl]-2-fluorobenzoyl]piperazine;
  • 4-[3-[[4-(Cyclopropylcarbonyl)piperazine-1-yl]carbonyl]-4-fluorobenzyl]phthalazine-1(2H)-one
  • 4-{[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorophenyl]methyl}-2H-phthalazin-1-one
  • PIPERAZINE, 1-(CYCLOPROPYLCARBONYL)-4-(5-((3,4-DIHYDRO-4-OXO-1-PHTHALAZINYL)METHYL)-2-FLUOROBENZOYL)-